相关实验视频

Updated: Sep 13, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

在青少年抑郁症中使用塞特拉林治疗后,大脑血液流动的动态

Wenyu Ren^1,2, Xiao Liu¹, Zhiwei Zhang¹

¹Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Frontiers in psychiatry

|August 4, 2025

概括

动脉旋转标记 (ASL) 揭示了抑郁症青少年脑血流 (CBF) 的改变. 塞特拉林治疗使一些CBF模式正常化,基线CBF在左中额头环预测治疗反应.

科学领域:

神经成像是一种神经成像.
药理干预措施药理干预措施
青少年精神病学青少年精神病学

背景情况:

青少年抑郁症与脑血流 (CBF) 异常有关.
在青少年中选择性血清素再吸收抑制剂 (SSRI) 对CBF变化的先前研究是有限的.
动脉旋转标签 (ASL) 提供了一种非侵入性的方法来评估CBF.

研究的目的:

在患有抑郁症的青少年接受了为期8周的塞特拉林治疗后调查CBF变化.
为了确定基线CBF是否可以预测治疗对塞特拉林的反应.
描述塞特拉林在青少年抑郁症中的神经生物学影响.

主要方法:

40名患有抑郁症的青少年和31名健康对照人接受了ASL的休息状态功能性MRI (rs-fMRI).
患有抑郁症的青少年接受了8周的塞特拉林治疗,随后进行了重复扫描.
使用SPM12和MATLAB分析了CBF变化;评估了与HAMD-17分数的相关性.

主要成果:

基线:患有抑郁症的青少年在后骨中表现出增加的CBF,在中圈 (MTG),轨道前圈和中前圈 (MFG) 中表现出减少的CBF.
治疗后:观察到右侧胰岛的CBF增加和右侧MTG的CBF减少.
基线CBF在左轨道前回形中与临床改善 (HAMD-17减少) 有积极的相关性.

结论:

在抑郁青少年和对照人群之间存在显著的CBF差异.
塞特拉林治疗诱导了特定的CBF变化,突出显示了治疗效果的关键大脑区域.
左MFG的基线CBF可以作为青少年抑郁症中塞特拉林治疗反应的预后生物标志物.

关键词:

青少年抑郁症青少年抑郁症动脉旋转标签的标记大脑的血液流动.抑郁抑郁症抑郁症抑郁症是一种功能磁力共振成像 (fMRI) 是一种功能共振成像.药物治疗药物治疗

更多相关视频

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

相关概念视频

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...